title: Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice?
authors.forename: Matteo
authors.initials: M
authors.lastname: Ravaioli
authors.forename: Gian Luca
authors.initials: GL
authors.lastname: Grazi
authors.forename: Matteo
authors.initials: M
authors.lastname: Cescon
authors.forename: Giorgio
authors.initials: G
authors.lastname: Ercolani
authors.forename: Antonio Daniele
authors.initials: AD
authors.lastname: Pinna
authors.forename: Fabio
authors.initials: F
authors.lastname: Piscaglia
authors.forename: Franco
authors.initials: F
authors.lastname: Trevisani
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000473:pathology* / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology* / Q000628:therapy*; D016031:Liver Transplantation; D020360:Neoadjuvant Therapy